CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $11,143,000 | -19.9% | 94,108 | -20.1% | 0.01% | -14.3% |
| Q4 2020 | $13,915,000 | +733.2% | 117,803 | +684.0% | 0.01% | +600.0% |
| Q3 2020 | $1,670,000 | +391.2% | 15,026 | +351.2% | 0.00% | – |
| Q2 2020 | $340,000 | -81.2% | 3,330 | -80.2% | 0.00% | -100.0% |
| Q1 2020 | $1,811,000 | +58.6% | 16,776 | +71.0% | 0.00% | +100.0% |
| Q4 2019 | $1,142,000 | +8.1% | 9,812 | +6.4% | 0.00% | 0.0% |
| Q3 2019 | $1,056,000 | -70.3% | 9,223 | -75.3% | 0.00% | -66.7% |
| Q2 2019 | $3,560,000 | -40.9% | 37,361 | -43.4% | 0.00% | -40.0% |
| Q1 2019 | $6,020,000 | -22.0% | 65,973 | -31.6% | 0.01% | -28.6% |
| Q3 2018 | $7,714,000 | +178.1% | 96,418 | +245.3% | 0.01% | +133.3% |
| Q2 2018 | $2,774,000 | -94.6% | 27,927 | -95.6% | 0.00% | -93.8% |
| Q1 2018 | $51,410,000 | +435.4% | 634,692 | +420.6% | 0.05% | +433.3% |
| Q4 2017 | $9,603,000 | +2202.9% | 121,905 | +2601.2% | 0.01% | – |
| Q3 2017 | $417,000 | – | 4,513 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Maso Capital Partners Ltd | 143,300 | $11,464,000 | 11.16% |
| Hillhouse Capital Management | 2,751,200 | $220,096,000 | 5.88% |
| York Capital Management Global Advisors, LLC | 1,167,643 | $93,411,000 | 2.95% |
| Kite Lake Capital Management (UK) LLP | 152,836 | $12,227,000 | 2.53% |
| RUDMAN ERROL M | 80,000 | $6,400,000 | 2.39% |
| Dalton Investments, Inc. | 54,551 | $4,364,000 | 2.04% |
| Greenwoods Asset Management Ltd | 245,000 | $19,600,000 | 1.91% |
| Point72 Hong Kong Ltd | 47,296 | $3,784,000 | 1.29% |
| Temasek Holdings (Private) Ltd | 990,000 | $79,200,000 | 0.46% |
| Kassirer Asset Management Corp | 6,000 | $480,000 | 0.32% |